20335353

Source:http://linkedlifedata.com/resource/pubmed/id/20335353

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0018801, umls-concept:C0205179, umls-concept:C0240526, umls-concept:C0241010, umls-concept:C0332281, umls-concept:C0520680, umls-concept:C0678226, umls-concept:C0700292, umls-concept:C1849744
pubmed:issue	4
pubmed:dateCreated	2010-3-25
pubmed:abstractText	Central sleep apnoea (CSA) and increased serum erythropoietin (EPO) concentration have each been associated with adverse prognosis in heart failure (HF) patients. The aim of this study was to examine the relationship between nocturnal hypoxaemia due to CSA and the serum EPO concentration in patients with HF.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1ULI RR024150, http://linkedlifedata.com/resource/pubmed/grant/HL65176, http://linkedlifedata.com/resource/pubmed/grant/HL70302, http://linkedlifedata.com/resource/pubmed/grant/HL73211
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-10086966, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-10880416, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-1244564, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-12490547, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-12682029, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-12897465, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-1400046, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-14499855, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-15234408, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-15363820, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-15664399, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-15956012, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-16380551, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-17161240, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-17276180, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-17562959, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-18437122, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-18495690, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-18702977, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-2002640, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-20335346, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-7633695, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-8059727, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-8960586, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-9623555, http://linkedlifedata.com/resource/pubmed/commentcorrection/20335353-9626176
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100887595
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Erythropoietin
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1879-0844
pubmed:author	pubmed-author:Badenhop-StevensNancyN, pubmed-author:CalvinAndrew DAD, pubmed-author:OlsonLyle JLJ, pubmed-author:Rio PerezJose AJA, pubmed-author:ScottChristopher GCG, pubmed-author:SomersVirend KVK, pubmed-author:SteensmaDavid PDP, pubmed-author:van der WaltChristelleC
pubmed:issnType	Electronic
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	354-9
pubmed:dateRevised	2011-7-27
pubmed:meshHeading	pubmed-meshheading:20335353-Aged, pubmed-meshheading:20335353-Anoxia, pubmed-meshheading:20335353-Biological Markers, pubmed-meshheading:20335353-Case-Control Studies, pubmed-meshheading:20335353-Disease Progression, pubmed-meshheading:20335353-Erythropoietin, pubmed-meshheading:20335353-Female, pubmed-meshheading:20335353-Health Status Indicators, pubmed-meshheading:20335353-Heart Failure, pubmed-meshheading:20335353-Humans, pubmed-meshheading:20335353-Linear Models, pubmed-meshheading:20335353-Male, pubmed-meshheading:20335353-Middle Aged, pubmed-meshheading:20335353-Multivariate Analysis, pubmed-meshheading:20335353-Oxygen Consumption, pubmed-meshheading:20335353-Polysomnography, pubmed-meshheading:20335353-Prognosis, pubmed-meshheading:20335353-Risk Factors, pubmed-meshheading:20335353-Severity of Illness Index, pubmed-meshheading:20335353-Sleep Apnea, Central, pubmed-meshheading:20335353-Statistics as Topic
pubmed:year	2010
pubmed:articleTitle	Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin.
pubmed:affiliation	Mayo School of Graduate Medical Education, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural